Anal Cancer pp 85-93 | Cite as

Management of Local-Regional Anal Cancer Recurrence

  • Shilpa S. Murthy
  • Elin R. Sigurdson


Anal cancer, a rare gastrointestinal disease, accounts for 1–2.5% of gastrointestinal cancers. Primary treatment is chemoradiation. Ten to 30% of patients experience local relapse, and salvage surgery is a second line of treatment for these patients. Wide local excision, abdominoperineal resection, pelvic exenteration with or without sacrectomy, and inguinal node dissection are all surgical options. In this chapter, we review the management and treatment options for patients who are initially treated with chemoradiation and experience local-regional recurrence of the disease.


Locoregional failure Recurrent anal cancer Salvage surgery Abdominoperineal resection Pelvic exoneration Inguinal node dissection Surgery for metastatic disease Salvage chemoradiation 





Abdominoperineal resection


Highly active antiretroviral therapy


Human immunodeficiency virus


Human papillomavirus


Magnetic resonance imaging


Squamous cell carcinoma


  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer Statistics. CA Cancer J Clin. 2017;67(1):7–30.Google Scholar
  2. 2.
    Nelson RA, Levine AM, Bernstein L, et al. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol. 2013;31:1569–75.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17:354–356.CrossRefGoogle Scholar
  4. 4.
    Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer. 1991;67:2462–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Cummings BJ. Concomitant radiotherapy and chemotherapy for anal cancer. Semin Oncol. 1992;19(4 suppl 11):102–8.PubMedGoogle Scholar
  6. 6.
    Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemo radiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527–39.CrossRefGoogle Scholar
  7. 7.
    Party UACW, UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049–54.CrossRefGoogle Scholar
  8. 8.
    Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–9.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 1999;85:1686–93.PubMedCrossRefGoogle Scholar
  10. 10.
    Guerra GR, Kong JC, Bernardi MP, Ramsay RG, Phillips WA, Warrier SK, et al. Salvage surgery for locoregional failure in anal squamous cell carcinoma. Dis Colon Rectum. 2018;61(2):179–86.PubMedCrossRefGoogle Scholar
  11. 11.
    Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68(3):794–800.CrossRefGoogle Scholar
  12. 12.
    Sammour T, Rodriguez-Bigas MA, Skibber JM. Locally recurrent disease related to anal canal cancers. Surg Oncol Clin N Am. 2017;26:115–25.PubMedCrossRefGoogle Scholar
  13. 13.
    Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol. 2004;5:149–57.PubMedCrossRefGoogle Scholar
  14. 14.
    Renehan AG, O’Dwyer ST. Management of local disease relapse. Color Dis. 2011;13(Suppl 1):44–52.CrossRefGoogle Scholar
  15. 15.
    Severino NP, Chadi SA, Rosen L. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival? Color Dis. 2016;18(10):959–66.CrossRefGoogle Scholar
  16. 16.
    Glynne-Jones G, Sebag-Montefiore D, Meadows HM, Cunningham D, Begum R, Adab F, et al. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomized controlled phase 3 trial. Lancet Oncol. 2017;18:347–56.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Morita SY, Bach CM, Klimberg VS, Pawlik TM, Posner MC, Tanabe KK. Textbook of complex general surgical oncology. New York: The Mc-Graw Hill Companies; 2017.Google Scholar
  18. 18.
  19. 19.
    Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol. 2008;15(5):263–78.PubMedCrossRefGoogle Scholar
  20. 20.
    Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999;44:127–31.CrossRefGoogle Scholar
  21. 21.
    Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum. 2009;52:624–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer. 1991;67:2462–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Boman BM, Moertel CG, O_Connell MJ, Scott M, Weiland LH, Beart RW, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 1984;54:114–25.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer. 1984;53:1285–93.PubMedCrossRefGoogle Scholar
  25. 25.
    Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med. 1989;87:221–4.CrossRefGoogle Scholar
  26. 26.
    Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, et al. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol. 2007;14(10):2807–16.PubMedCrossRefGoogle Scholar
  27. 27.
    Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:1165–76.PubMedCrossRefGoogle Scholar
  28. 28.
    Renehan AG, Saunders MP, Schofield PF, O’Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg. 2005;92(5):605–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM, et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007;14:478–83.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Akbari RP, Paty PB, Guillern JG, Weiser MR, Temple LK, Minsky BD, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum. 2004;47(7):1136–44.PubMedCrossRefGoogle Scholar
  31. 31.
    Lefevre JH, Corte H, Tiret E, Boccara D, Chaouat M, Touboul E, et al. Abdominoperineal resection for squamous cell anal carcinoma: survival and risk factors for recurrence. An Surg Oncol. 2012;19(13):4186–92.CrossRefGoogle Scholar
  32. 32.
    Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol. 1994;1(2):105–10.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum. 1998;41(12):1488–93.PubMedCrossRefGoogle Scholar
  34. 34.
    Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter conserving treatment. Cancer. 1999;86(3):405–9.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Van der Wal BC, Cleffken BI, Gulec B, Kaufman HS, Choti MA. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg. 2001;5(4):383–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Smith AJ, Whelan P, Cummings BJ, Stern HS. Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection. Acta Oncol. 2001;40(1):34–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89(11):1425–9.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Ghouti L, Houvenaeghel G, Moutardier V, Giovannini M, Magnin V, Lelong B, et al. Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum. 2005;48(1):16–22.PubMedCrossRefGoogle Scholar
  39. 39.
    Schiller DE, Cummings BJ, Rai S, Le LW, Last L, Davey P, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol. 2007;14(10):2780–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Mariani P, Ghanneme A, De la Rochefordiere A, Girodet J, Falcou MC, Salmon RJ. Abdominoperineal resection for anal cancer. Dis Colon Rectum. 2008;51(10):1459–501.CrossRefGoogle Scholar
  41. 41.
    Eeson G, Foo M, Harrow S, McGregor G, Hay J. Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment. Am J Surg. 2011;201:628–33.PubMedCrossRefGoogle Scholar
  42. 42.
    Correa JHS, Castro LS, Kesley R, Dias JA, Jesus JP, Olivatto LO, et al. Salvage abdominoperineal resection for anal cancer following chemoradiation: a proposed scoring system for predicting postoperative survival. J Surg Oncol. 2013;107:486–92.PubMedCrossRefGoogle Scholar
  43. 43.
    Skibber J, Rodriguez-Bigas MA, Gordon PH. Surgical considerations in anal cancer. Surg Oncol Clin N Am. 2004;13(2):321–38.PubMedCrossRefGoogle Scholar
  44. 44.
    Solomon MJ, Tan KK, Bromilow RG, Al-mozany N, Lee PJ. Sacrectomy via the abdominal approach during pelvic exenteration. Dis Colon Rectum. 2014;57(2):272–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Sunesen KG, Buntzen S, Tei T, Lindegaard JC, Norgaard M, Laurberg S. Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous (VRAM) flap. Ann Surg Oncol. 2009;16:68–77.PubMedCrossRefGoogle Scholar
  46. 46.
    Bakx R, van Lanschot JJ, Zoetmulder FA. Inferiorly based rectus abdominis myocutaneous flaps in surgical oncology: indications, technique, and experience in 37 patients. J Surg Oncol. 2004;85:93–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Khoo AK, Skibber JM, Nabawi AS, Gurlek A, Youssef AA, Wang B, et al. Indications for immediate tissue transfer for soft tissue reconstruction in visceral pelvic surgery. Surgery. 2001;130(3):463–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Davidge KM, Raghuram K, Hofer SO, Ferguson PC, Wunder JS, Swallow CJ, et al. Impact of flap reconstruction on perineal wound complications following ablative surgery for advanced and recurrent rectal cancers. Ann Surg Oncol. 2014;21(6):2068–73.PubMedCrossRefGoogle Scholar
  49. 49.
    Chong TW, Balch GC, Kehoe SM, Margulis V, Saint-Cyr M. Reconstruction of large perineal and pelvic wounds using Gracilis muscle flaps. Ann Surg Oncol. 2015;22(11):3738–44.PubMedCrossRefGoogle Scholar
  50. 50.
    Boccola MA, Rozen WM, Ek EW, Teh BM, Croxford M, Grinsell D. Inferior gluteal artery myocutaneous island transposition flap reconstruction of irradiated perineal defects. J Plast Reconstr Aesthet Surg. 2010;63(7):1169–75.PubMedCrossRefGoogle Scholar
  51. 51.
    Pantelides NM, Davies RJ, Fearnhead NS, Malata CM. The gluteal fold flap: a versatile option for perineal reconstruction following anorectal cancer resection. J Plast Reconstr Aesthet Surg. 2013;66(6):812–20.PubMedCrossRefGoogle Scholar
  52. 52.
    Wong S, Garvey P, Skibber J, Yu P. Reconstruction of pelvic exenteration defects with anterolateral thigh-vastus lateralis muscle flaps. Plast Reconstr Surg. 2009;124(4):1177–85.PubMedCrossRefGoogle Scholar
  53. 53.
    Tashiro J, Yamaguchi S, Ishii T, Suwa H, Kondo H, Suzuki A, et al. Salvage total pelvic exenteration with bilateral v-y advancement flap reconstruction for locally recurrent rectal cancer. Case Rep Gastroenterol. 2013;7(1):175–81.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Flam MS, John MJ, Mowry PA, Lovalvo LJ, Ramalho LD, Wade J. Definitive combined modality therapy of carcinoma of the anus. A report of 30 cases including results of salvage therapy in patients with residual disease. Dis Colon Rectum. 1987;30(7):495–502.PubMedCrossRefGoogle Scholar
  55. 55.
    Wade DS, Herrera L, Castillo NB, Petrelli NJ. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet. 1989;169:238–42.PubMedGoogle Scholar
  56. 56.
    Davey P, Saibil EA, Wong R. Bipedal lymphography in the management of carcinoma of the anal canal. Br J Radiol. 1996;69:632–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Shridhar R, Shibata D, Chan E, Thomas CR. Anal Cancer: current standards in care and recent changes in practice. CA Cancer J Clin. 2015;65:139–62.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer. 2001;92:77–84.PubMedCrossRefGoogle Scholar
  59. 59.
    Ortholan C, Resbeut M, Hannoun-Levi JM, Teissier E, Gerard JP, Ronchin P, et al. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study). Int J Radiat Oncol Biol Phys. 2012;82:1988–95.PubMedCrossRefGoogle Scholar
  60. 60.
    Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J AIDS. 2010;53:124–30.Google Scholar
  61. 61.
    Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29.PubMedCrossRefGoogle Scholar
  62. 62.
    Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomark Prev. 2011;20:2551–9.CrossRefGoogle Scholar
  63. 63.
    Cunnin L, Wali AWM, Turner J, Bower M, Ion L, Allen-Mersh T. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after Chemoradiotherapy in HIV-positive individuals. Ann Surg Oncol. 2014;21:527–32.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Shilpa S. Murthy
    • 1
  • Elin R. Sigurdson
    • 1
  1. 1.Department of Surgical Oncology, Fox Chase Cancer CenterTemple UniversityPhiladelphiaUSA

Personalised recommendations